Russell M E, Wallace A F, Wyner L R, Newell J B, Karnovsky M J
Harvard Medical School, Massachusetts General Hospital, Boston, USA.
Circulation. 1995 Aug 1;92(3):457-64. doi: 10.1161/01.cir.92.3.457.
The Lewis-F344 rat cardiac transplantation model produces cardiac allografts with chronic rejection characterized by arteriosclerotic lesions composed of macrophages and smooth muscle cells. Modulation of the inflammatory response with a diet deficient in essential fatty acids protects against the development of intimal thickening. Little is known about the components of the inflammatory response mediating this process. The cytokine-inducible isoform of nitric oxide synthase (iNOS) regulates the high-output nitric oxide pathway that confers activation properties to macrophages and regulates vasomotion, monocyte adherence, and smooth muscle cell proliferation in the vasculature. The purpose of the present study was to determine whether the iNOS pathway was upregulated during the course of chronic cardiac rejection.
We studied iNOS mRNA and protein expression patterns in a series of Lewis-F344 cardiac allografts with early and late chronic rejection and after modulation of the inflammatory response (in an effort to attenuate arteriosclerosis). Relative gene transcript levels were measured with a 32P-dCTP reverse-transcriptase polymerase chain reaction assay designed to amplify iNOS mRNA. The distribution of the iNOS gene product was examined by immunocytochemistry with a polyclonal antibody against iNOS. NOS transcript levels increased significantly in cardiac allografts (days 7, 14, 28, and 75) compared with paired host hearts (exposed to the same circulation) and syngrafts (P < .003). Immunostaining localized the iNOS antigen within subpopulations of mononuclear inflammatory cells in cardiac allografts--presumably, activated macrophages. The number of iNOS-positive mononuclear cells was 25-fold higher in cardiac allografts compared with paired host hearts and syngrafts (P < .009). In cardiac allografts of 75 days or older, there also was striking iNOS staining within some medial and intimal smooth muscle cells in various vessels. Modulation of the inflammatory response (with a diet deficient in essential fatty acids) produced significant decreases in the intimal thickening score and in the percentage of diseased vessels in 28-day cardiac allografts compared with allografts from rats fed a control diet. There was a correlate decrease in iNOS transcript levels and in the number of iNOS-positive mononuclear cells in the 28-day cardiac allografts from rats fed the essential fatty acid-deficient diet.
The early and persistent upregulation of iNOS in chronic cardiac rejection and the coincident reduction in arteriosclerosis and downregulation of iNOS suggest that this inducible regulator may contribute to the inflammatory response mediating transplant arteriosclerosis.
Lewis-F344大鼠心脏移植模型产生的心脏同种异体移植物会发生慢性排斥反应,其特征为出现由巨噬细胞和平滑肌细胞组成的动脉粥样硬化病变。用缺乏必需脂肪酸的饮食调节炎症反应可预防内膜增厚的发生。关于介导这一过程的炎症反应成分知之甚少。细胞因子诱导型一氧化氮合酶(iNOS)调节高输出一氧化氮途径,该途径赋予巨噬细胞激活特性,并调节血管运动、单核细胞黏附以及血管平滑肌细胞增殖。本研究的目的是确定在慢性心脏排斥反应过程中iNOS途径是否上调。
我们研究了一系列Lewis-F344心脏同种异体移植物在早期和晚期慢性排斥反应时以及炎症反应调节后(旨在减轻动脉粥样硬化)的iNOS mRNA和蛋白表达模式。用设计用于扩增iNOS mRNA的32P-dCTP逆转录聚合酶链反应测定相对基因转录水平。用抗iNOS的多克隆抗体通过免疫细胞化学检查iNOS基因产物的分布。与配对的宿主心脏(暴露于相同循环)和同基因移植物相比,心脏同种异体移植物(第7、14、28和75天)中的NOS转录水平显著升高(P <.003)。免疫染色将iNOS抗原定位在心脏同种异体移植物中的单核炎症细胞亚群内——推测为活化的巨噬细胞。与配对的宿主心脏和同基因移植物相比,心脏同种异体移植物中iNOS阳性单核细胞的数量高25倍(P <.009)。在75天及以上的心脏同种异体移植物中,各种血管的一些中层和内膜平滑肌细胞内也有明显的iNOS染色。与喂食对照饮食的大鼠的同种异体移植物相比,炎症反应调节(用缺乏必需脂肪酸的饮食)使28天心脏同种异体移植物的内膜增厚评分和病变血管百分比显著降低。喂食缺乏必需脂肪酸饮食的大鼠的28天心脏同种异体移植物中,iNOS转录水平和iNOS阳性单核细胞数量相应减少。
慢性心脏排斥反应中iNOS的早期和持续上调以及动脉粥样硬化的同时减轻和iNOS的下调表明,这种诱导型调节因子可能有助于介导移植动脉粥样硬化的炎症反应。